Adaptive responses of the HER2+ SKBR-3 and BT474m1 cell lines to lapatinib and JQ1
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
SKBR-3 or BT474m1 HER2+ breast cancer cells were treated with either DMSO, 300nM lapatinib, 300nM JQ1, or lapatinib and JQ1 in combination for 48h. 8 experimental samples
创建时间：
2023-05-10
